These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8528853)

  • 1. Effect of prescribing guidelines on the use of neuromuscular blocking agents.
    Gora-Harper ML; Hessel E; Shadick D
    Am J Health Syst Pharm; 1995 Sep; 52(17):1900-4. PubMed ID: 8528853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of neuromuscular blocking drugs in the intensive care unit: a US perspective.
    Murray MJ; Strickland RA; Weiler C
    Intensive Care Med; 1993; 19 Suppl 2():S40-4. PubMed ID: 8106677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a cost containment program on the use of volatile anesthetics and neuromuscular blocking drugs.
    Szocik JF; Learned DW
    J Clin Anesth; 1994; 6(5):378-82. PubMed ID: 7986509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blockers in surgery and intensive care, Part 2.
    McManus MC
    Am J Health Syst Pharm; 2001 Dec; 58(24):2381-95. PubMed ID: 11794954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of on-demand vs deep neuromuscular relaxation on rating of surgical and anaesthesiologic conditions in patients undergoing thoracolaparoscopic esophagectomy (DEPTH trial): study protocol for a randomized controlled trial.
    Veelo DP; Gisbertz SS; Hannivoort RA; van Dieren S; Geerts BF; van Berge Henegouwen MI; Hollmann MW
    Trials; 2015 Aug; 16():331. PubMed ID: 26242177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Anaphylaxis Management in a Pediatric Emergency Department.
    Sidhu N; Jones S; Perry T; Thompson T; Storm E; Melguizo Castro MS; Nick TG
    Pediatr Emerg Care; 2016 Aug; 32(8):508-13. PubMed ID: 27490724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blockers in surgery and intensive care, Part 1.
    McManus MC
    Am J Health Syst Pharm; 2001 Dec; 58(23):2287-99. PubMed ID: 11763807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations and Low-Technology Safety Solutions Following Neuromuscular Blocking Agent Incidents.
    Graudins LV; Downey G; Bui T; Dooley MJ
    Jt Comm J Qual Patient Saf; 2016 Feb; 42(2):86-91. PubMed ID: 26803037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of neuromuscular blocking agents by air medical services.
    Sayre MR; Weisgerber I
    J Air Med Transp; 1992 Jan; 11(1):7-11. PubMed ID: 10117684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmaceutical services on adherence to criteria-for-use guidelines in the operating room.
    Higgins B; Patel P; Bach DS
    Am J Health Syst Pharm; 1999 May; 56(10):977-82. PubMed ID: 10365721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.
    Weiner SG; Baker O; Poon SJ; Rodgers AF; Garner C; Nelson LS; Schuur JD
    Ann Emerg Med; 2017 Dec; 70(6):799-808.e1. PubMed ID: 28549620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Price stickers do not alter drug usage.
    Horrow JC; Rosenberg H
    Can J Anaesth; 1994 Nov; 41(11):1047-52. PubMed ID: 7828250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving cost-effectiveness of hypertension management at a community health centre.
    Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K
    S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of inadequate neuromuscular blockade during general anesthesia.
    Dubovoy T; Shanks AM; Devine S; Kheterpal S
    J Clin Anesth; 2017 Feb; 36():16-20. PubMed ID: 28183558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada.
    Rahme E; Toubouti Y; Lelorier J
    J Rheumatol; 2006 Mar; 33(3):588-96. PubMed ID: 16463432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization pattern and cost of sedation, analgesia and neuromuscular blockade in a multidisciplinary intensive care unit.
    Hariharan S; Pillai G; Chen D; Soogrim S; Nelson J; Tsoi-a-Fatt R; Mohan K; Boodhai V
    West Indian Med J; 2008 Mar; 57(2):112-7. PubMed ID: 19565952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.